tirzepatide approved for weight loss (ZEPBOUND) Chronic Management in Adults with Obesity ✨ The FDA has approved Zepbound (tirzepatide) for chronic weight management in adults with obesity (BMI of 30 kg/ m2 or Tirzepatide Wins FDA Approval for
Description
That single fact is responsible for nearly every dosing error reported to the FDA

Results Phytochemical Profiling of Moringa oleifera Extract Phytochemical characterization of MO revealed that the extract possessed a total phenolic content (TPC) of 1374.25 69.08 g gallic acid equivalents per mL (g GAE/mL) and a total flavonoid content (TFC) of 1042.86 51.51 g rutin equivalents per mL (g RE/mL), indicating a rich abundance of polyphenolic and flavonoid constituents

How GLP-1 Medications Affect Medication Absorption GLP-1 receptor agonists work by slowing the rate at which food and liquids move from your stomach into your small intestine

BMJ 348 , g3244 (2014)

4, the three most frequently reported SOC categories were "Gastrointestinal disorders," "General disorders and administration site conditions," and "Investigations." Notably, while "Injury, poisoning, and procedural complications" and "Nervous system disorders" demonstrated higher reporting frequencies compared to other SOCs, these associations did not reach statistical significance in our analysis, suggesting potential reporting bias or confounding factors that warrant further investigation

There are documented case reports of extreme appetite suppression and psychiatric complications requiring GLP-1 discontinuation in people with restrictive eating patterns ( Leziak et al., J Psychiatric Research, 2026 )
